20 Participants Needed

High-Intensity Gait Training for Multiple Sclerosis

BT
Overseen ByBrice T Cleland, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Illinois at Chicago
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

Nearly 1 million individuals in the United States have multiple sclerosis, which causes fatigue and problems with walking. Fatigue and walking problems are poorly treated, but exercise training, particularly high-intensity walking exercise, may help. This provide insight into whether high-intensity walking exercise can improve fatigue and walking problems in people with multiple sclerosis, which could improve quality of life and reduce economic burden.

Are You a Good Fit for This Trial?

This trial is for people with Multiple Sclerosis who experience fatigue and walking difficulties. Specific eligibility criteria are not provided, but typically participants must meet certain health conditions to ensure safety and effectiveness of the treadmill training intervention.

Inclusion Criteria

I am 21 years old or older.
I have been diagnosed with multiple sclerosis.
My treatment for my condition has not changed in the last 6 months.
See 3 more

Exclusion Criteria

Prisoners
Significant cognitive or communication impairment (Mini-Mental State Examination (MMSE)<21), which could impede the understanding of the purpose of procedures of the study or prevent the patient from performing the ankle-tracking task
I have been diagnosed with severe osteoporosis.
See 13 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo either moderate-intensity continuous treadmill training or high-intensity interval treadmill training to improve fatigue and walking in people with MS

6 weeks
2 visits per week (in-person)

Follow-up

Participants are monitored for changes in corticomotor excitability, fatigue impact, walking speed, and other outcomes immediately before and after training

1 week

What Are the Treatments Tested in This Trial?

Interventions

  • Treadmill Training
Trial Overview The study investigates if high-intensity gait training on a treadmill can reduce fatigue and improve walking in individuals with Multiple Sclerosis. The goal is to see if this type of exercise could enhance their quality of life.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: High-intensity interval treadmill trainingExperimental Treatment1 Intervention
Group II: Moderate-intensity continuous treadmill trainingActive Control1 Intervention

Treadmill Training is already approved in China for the following indications:

🇨🇳
Approved in China as Remote Ischemic Conditioning for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Illinois at Chicago

Lead Sponsor

Trials
653
Recruited
1,574,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security